Arkolith/Insider Trading/BTTX/Form 4

Heinen Mark

See RemarksBetter Therapeutics, Inc. (BTTX) · full profile →Form 4 · filed Dec 15, 2021
Net Buying
Open-Market Buys
$16K
Open-Market Sells
$0
Net Open-Market Flow
$16K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 15, 2021Buy(P)2K$4.70$11K10K
Dec 14, 2021Buy(P)500$5.44$3K8K
Dec 13, 2021Buy(P)500$5.45$3K7K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-21-048374) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML